Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Olanzapine Viatris (previously Olanzapine Mylan)“
Suchtreffer
Begriffe & Kennungen
Olanzapine Viatris (previously Olanzapine Mylan) · 4.8 Undesirable effects · 1
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Follow
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 10 3 Observed for fasting normal levels at baseline (< 5.17 mmol/l) which increased to high (≥ 6.2 mmol/l). Ch
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 11 In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulte
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 12 professionals are asked to report any suspected adverse reactions via the national reporting system listed
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 8 common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000)
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · 9 including constipation and dry mouth Hepatobiliary disorders Transient, Hepatitis (including asymptomatic he
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Additional information on special populations In clinical trials in elderly patients with dementia, olanzapine
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Adults The most frequently (seen in ≥ 1 % of patients ) reported adverse reactions associated with the use of
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Amnesia9
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Dysarthria Stuttering11 Restless legs syndrome11 Cardiac disorders Bradycardia Ventricular QTc prolongation (s
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Immune system disorders Hypersensitivity11 Metabolism and nutrition disorders Weight gain1 Elevated cholestero
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Long-term exposure (at least 48 weeks) The proportion of patients who had adverse, clinically significant chan
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Metabolism and nutrition disorders Very common: Weight gain13, elevated triglyceride levels14, increased appet
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Nervous system disorders Somnolence Dizziness Seizures where in most Neuroleptic malignant Akathisia6 cases a
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Paediatric population Olanzapine is not indicated for the treatment of children and adolescent patients below
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Summary of the safety profile
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.8 · Tabulated list of adverse reactions The following table lists the adverse reactions and laboratory investigati
Eintrag öffnen